Steven K. Jones, Ph.D.
About Steven K. Jones, Ph.D.
Steven K. Jones, Ph.D., serves as the Director of Global Franchise Medical Affairs and Opinion Leader Strategy Lead at Kite Pharma, bringing over five years of experience in the pharmaceutical industry, particularly in B-cell malignancies and CAR-T cell therapy.
Current Role at Kite Pharma
Steven K. Jones, Ph.D. serves as the Director of Global Franchise Medical Affairs and Opinion Leader Strategy Lead at Kite Pharma. He has held this position since 2023. In this role, he focuses on developing strategies for engaging opinion leaders within the medical community, particularly in the field of Hematology Oncology.
Previous Experience at Kite Pharma
Prior to his current role, Steven K. Jones worked at Kite Pharma as a Senior Medical Science Liaison from 2019 to 2023, covering the Michigan and Ohio regions. He also served as a Principal Medical Science Liaison for six months in 2023. His experience at Kite Pharma contributed to his expertise in CAR-T cell therapy and B-cell malignancies.
Experience at The Janssen Pharmaceutical Companies
Steven K. Jones was employed at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Medical Science Liaison specializing in Hematology Oncology from 2018 to 2019. His work in this role was concentrated in the Greater Pittsburgh and Buffalo area, where he further developed his knowledge in oncology.
Educational Background
Steven K. Jones obtained his Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology from Wayne State University School of Medicine, where he studied from 2012 to 2017. He also holds a Bachelor’s Degree in Biochemistry from the University of Detroit Mercy, which he completed from 2008 to 2012.
Early Career and Research Experience
Before entering the pharmaceutical industry, Steven K. Jones worked as a Graduate Research Assistant at Wayne State University from 2012 to 2017. He also held positions at MI Bioresearch, first as an Associate Scientist in Pharmacology Operations for nine months in 2017, and then as Team Lead for R&D Operations from 2017 to 2018. His early career focused on research and development in the life sciences.